BusinessPPJ Healthcare Enterprises, Inc. CEO to Cancel 2,500,000,000 of Her Own Common Shares & Increase Ownership Stake of All Other Common StockholdersBy Nasdaq OMXJan 21, 2016, 5:08 PM UTC
BusinessCancer Genetics Launches Comprehensive Immuno-Oncology Testing Portfolio For Use in Clinical Trials, Translational Research, and Therapy Selection for PatientsBy Nasdaq OMXJan 21, 2016, 1:00 PM UTC
BusinessStarkey Hearing Technologies Joins Forces with Bragi to Transform Hearable and Wearable TechnologyBy Nasdaq OMXJan 20, 2016, 6:07 PM UTC
BusinessZafgen's Pivotal Phase 3 Trial of Beloranib in Prader-Willi Syndrome Achieves Co-Primary Efficacy EndpointsBy Nasdaq OMXJan 20, 2016, 11:00 AM UTC
BusinessAffimed to Host Hodgkin's Lymphoma Day with Key Opinion Leaders on January 26th in New York CityBy Nasdaq OMXJan 20, 2016, 10:00 AM UTC
BusinessGlobus Medical Announces Litigation Settlement AgreementBy Nasdaq OMXJan 19, 2016, 10:08 PM UTC
BusinessNewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in Patients With Metastatic Pancreatic Cancer at ASCO GIBy Nasdaq OMXJan 19, 2016, 10:00 PM UTC
